Lido Advisors LLC raised its stake in The Allstate Co. (NYSE:ALL - Free Report) by 6.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 34,085 shares of the insurance provider's stock after buying an additional 2,153 shares during the quarter. Lido Advisors LLC's holdings in Allstate were worth $6,601,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. VSM Wealth Advisory LLC purchased a new stake in shares of Allstate in the 4th quarter valued at approximately $25,000. Twin Tree Management LP acquired a new position in shares of Allstate in the 4th quarter valued at $27,000. Vision Financial Markets LLC purchased a new position in shares of Allstate during the 4th quarter worth $29,000. Hopwood Financial Services Inc. purchased a new stake in Allstate in the 4th quarter valued at about $29,000. Finally, Aster Capital Management DIFC Ltd acquired a new position in Allstate in the fourth quarter valued at about $40,000. Institutional investors and hedge funds own 76.47% of the company's stock.
Insider Buying and Selling at Allstate
In other news, CFO Jesse E. Merten sold 40,102 shares of the company's stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the sale, the chief financial officer now directly owns 18,115 shares of the company's stock, valued at approximately $3,378,990.95. This represents a 68.88 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.80% of the stock is owned by company insiders.
Allstate Stock Up 1.0 %
Shares of NYSE:ALL traded up $1.91 during trading on Friday, hitting $199.15. 1,508,513 shares of the company were exchanged, compared to its average volume of 1,619,299. The firm's 50 day moving average price is $198.49 and its 200-day moving average price is $194.88. The Allstate Co. has a 12-month low of $156.66 and a 12-month high of $212.91. The company has a debt-to-equity ratio of 0.42, a current ratio of 0.36 and a quick ratio of 0.40. The stock has a market capitalization of $52.80 billion, a P/E ratio of 11.72, a PEG ratio of 1.01 and a beta of 0.32.
Allstate (NYSE:ALL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $3.53 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.98 by ($0.45). Allstate had a net margin of 7.28% and a return on equity of 28.20%. The company had revenue of $14.30 billion during the quarter, compared to analyst estimates of $16.41 billion. During the same quarter in the prior year, the company earned $5.13 EPS. The business's revenue was up 7.8% on a year-over-year basis. On average, research analysts predict that The Allstate Co. will post 18.74 earnings per share for the current fiscal year.
Allstate announced that its board has approved a stock buyback plan on Wednesday, February 26th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the insurance provider to purchase up to 3% of its shares through open market purchases. Shares buyback plans are often an indication that the company's leadership believes its shares are undervalued.
Allstate Increases Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a dividend of $1.00 per share. This is a positive change from Allstate's previous quarterly dividend of $0.92. The ex-dividend date was Monday, March 10th. This represents a $4.00 annualized dividend and a yield of 2.01%. Allstate's payout ratio is 27.32%.
Analysts Set New Price Targets
Several brokerages have recently commented on ALL. Keefe, Bruyette & Woods decreased their price objective on shares of Allstate from $240.00 to $228.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Barclays decreased their price target on Allstate from $183.00 to $172.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. Evercore ISI boosted their price objective on Allstate from $227.00 to $230.00 and gave the company an "outperform" rating in a report on Thursday. JPMorgan Chase & Co. raised their target price on Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. Finally, Wells Fargo & Company boosted their price target on shares of Allstate from $186.00 to $187.00 and gave the stock an "equal weight" rating in a research note on Tuesday, January 14th. One analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average price target of $221.60.
Read Our Latest Stock Report on ALL
Allstate Company Profile
(
Free Report)
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More

Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.